C F Opitz|W Kirch|E A Mueller|D Pittrow - JoVE Visualize

Showing results (1-10 of 373) with videos related to

Pageof 38

Sort By:

European Journal of Clinical Investigation|April 2, 2009

Bleeding events in pulmonary arterial hypertensionC F Opitz, W Kirch, E A Mueller, et al.

Current Medical Research and Opinion|October 7, 2004

The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary careP Bramlage, D Pittrow, W Kirch

Deutsche Medizinische Wochenschrift (1946)|September 27, 2002

[Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care]D Pittrow, J Krappweis, W Kirch

European Journal of Clinical Investigation|February 11, 2005

Current concepts for the prevention of venous thromboembolismP Bramlage, D Pittrow, W Kirch

MMW Fortschritte Der Medizin|October 20, 2004

[IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting]H Lehnert, P Bramlage, D Pittrow, et al.

Clinical Drug Investigation|May 23, 2007

Regression of microalbuminuria in type 2 diabetics after switch to irbesartan treatment : an observational study in 38 016 patients in primary careH Lehnert, P Bramlage, D Pittrow, et al.

Clinical Drug Investigation|May 31, 2007

Cardiovascular Parameters during Submaximal Exercise following Submucous Administration of Articaine : A Comparison with Lidocaine and Placebo in Young Healthy VolunteersD Pittrow, C Schindler, U Maywald, et al.

Deutsche Medizinische Wochenschrift (1946)|March 12, 2010

[Clinical pharmacology and electrophysiological properties of dronedarone]T Lewalter, D Pittrow, A Goette, et al.

Deutsche Medizinische Wochenschrift (1946)|September 1, 2009

[International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)]D Pittrow, H A Ghofrani, C F Opitz, et al.

Addiction (Abingdon, England)|October 2, 2003

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological dataG Hajak, W E Müller, H U Wittchen, et al.

Pageof 38

Showing results (1-10 of 373) with videos related to

Sort By:

Pageof 38

European Journal of Clinical Investigation|April 2, 2009

Bleeding events in pulmonary arterial hypertensionC F Opitz, W Kirch, E A Mueller, et al.

Current Medical Research and Opinion|October 7, 2004

The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary careP Bramlage, D Pittrow, W Kirch

Deutsche Medizinische Wochenschrift (1946)|September 27, 2002

[Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care]D Pittrow, J Krappweis, W Kirch

European Journal of Clinical Investigation|February 11, 2005

Current concepts for the prevention of venous thromboembolismP Bramlage, D Pittrow, W Kirch

MMW Fortschritte Der Medizin|October 20, 2004

[IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting]H Lehnert, P Bramlage, D Pittrow, et al.

Clinical Drug Investigation|May 23, 2007

Regression of microalbuminuria in type 2 diabetics after switch to irbesartan treatment : an observational study in 38 016 patients in primary careH Lehnert, P Bramlage, D Pittrow, et al.

Clinical Drug Investigation|May 31, 2007

Cardiovascular Parameters during Submaximal Exercise following Submucous Administration of Articaine : A Comparison with Lidocaine and Placebo in Young Healthy VolunteersD Pittrow, C Schindler, U Maywald, et al.

Deutsche Medizinische Wochenschrift (1946)|March 12, 2010

[Clinical pharmacology and electrophysiological properties of dronedarone]T Lewalter, D Pittrow, A Goette, et al.

Deutsche Medizinische Wochenschrift (1946)|September 1, 2009

[International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)]D Pittrow, H A Ghofrani, C F Opitz, et al.

Addiction (Abingdon, England)|October 2, 2003

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological dataG Hajak, W E Müller, H U Wittchen, et al.

Pageof 38